Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Effectiveness of Aquamin® in Mitigating Halitosis [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the effectiveness of Aquamin in mitigating halitosis and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aquamin

Snippet

Sponsor: University of Michigan | Conditions: Healthy, Halitosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING